Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
IVVD Invivyd
1.880-0.160-7.84%
Close
02/08 16:00 ET
1.940+0.060+3.19%
Post Mkt Price 02/08 19:07 ET
High
2.030
Open
2.000
Turnover
343.87K
Low
1.830
Pre Close
2.040
Volume
182.85K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Invivyd, Inc. - IVVD, ADGI
CEDARHURST, N.Y., Feb. 8, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Invivyd, Inc. (the "Company") (NasdaqGM: IVVD) f/k/a Adagi
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Invivyd, Inc. F/k/a Adagio Therapeutics, Inc. - IVVD; ADGI
Invivyd Class Action: Levi & Korsinsky Reminds Invivyd, Inc. F/k/a Adagio Therapeutics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of April 3, 2023 - IVVD
New York, New York--(Newsfile Corp. - February 8, 2023) - Levi & Korsinsky, LLP notifies investors in Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. ("Invivyd" or the "Company") (NASDAQ: IVVD) of a cla
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Invivyd, Inc. F/k/a Adagio Therapeutics, Inc. (IVVD)
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming April 3, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who pur
Bronstein, Gewirtz & Grossman, LLC Notifies Invivyd, Inc. F/k/a Adagio Therapeutics, Inc. (IVVD) Investors of Class Action and to Actively Participate
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ENVX, IVVD and RVYL
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Invivyd, Inc. F/k/a Adagio Therapeutics, Inc. With Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - February 8, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Invivyd, Inc. f/k
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Invivyd, Inc. F/k/a Adagio Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 3, 2023 - (NASDAQ: IVVD)
INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 3, 2023 to file le
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Invivyd, Inc. F/k/a Adagio Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 3, 2023 - (IVVD)
New York, New York--(Newsfile Corp. - February 7, 2023) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Invivyd, Inc. f/k/a Adagio T
Company Overview
More
Invivyd, Inc.(formerly Adagio Therapeutics, Inc.) engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.
CEO： Mr. David Hering
Market： NASDAQ
Listing Date： 08/06/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet